BRANDI KAUFMAN: Open Payments
NPI 1891321428 · AUSTINTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 44 payments from 12 companies in 2025. Trend: 2023 $1,838 · 2024 $962 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $165 |
| ABBVIE INC. | 9 | $164 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| Lundbeck LLC | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Alkermes, Inc. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $18 |
Products named: VRAYLAR, ABILIFY MAINTENA, AUSTEDO XR, CAPLYTA, INVEGA SUSTENNA, TRINTELLIX, UZEDY, REXULTI.
Industry payments across OH — which companies pay providers there.
